Rita Medical Seeks Higher-Paying APC For Starburst Needles
This article was originally published in The Gray Sheet
Limited OPPS claims data for Rita Medical's Starburst XLi and Flex radiofrequency ablation disposable needles are responsible for an insufficient proposed payment for the procedure, according to the firm
You may also be interested in...
The American Hospital Association's contention that CMS should not reinstate "C" codes for device-tracking purposes under the hospital OPPS pits the organization against the device industry
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Commissioner Hahn’s tweet announcing a return to inspections, while not a new policy, may be signal that FDA understands sponsor concerns with the agency’s limited ability to conduct onsite inspections. Effort may be aimed at reassuring industry even as CRLs related to manufacturing increase.